Mirati Therapeutics Stock Price Chart

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRTX is experiencing slight selling pressure.

Mirati Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 41.42 Sell
20-day SMA: 42.95 Sell
50-day SMA: 45.98 Sell
200-day SMA: 62.05 Sell
8-day EMA: 41.57 Sell
20-day EMA: 43.04 Sell
50-day EMA: 46.55 Sell
200-day EMA: 63.6 Sell

Mirati Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.73 Sell
Relative Strength Index (14 RSI): 39.46 Sell
Chaikin Money Flow: -134301 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.06 - 46.7) Sell
Bollinger Bands (100): (38.55 - 69.69) Sell

Mirati Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Mirati Therapeutics Stock

Is Mirati Therapeutics Stock a Buy?

MRTX Technical Analysis vs Fundamental Analysis

Mirati Therapeutics (MRTX) is a Sell

Is Mirati Therapeutics a Buy or a Sell?

Mirati Therapeutics Stock Info

Market Cap:
Price in USD:
Share Volume:

Mirati Therapeutics 52-Week Range

52-Week High:
52-Week Low:
Mirati Therapeutics (MRTX) is a Sell

Mirati Therapeutics Share Price Forecast

Is Mirati Therapeutics Stock a Buy?

  • Mirati Therapeutics share price is 40.72 while MRTX 8-day exponential moving average is 41.57, which is a Sell signal.
  • The stock price of MRTX is 40.72 while Mirati Therapeutics 20-day EMA is 43.04, which makes it a Sell.
  • Mirati Therapeutics 50-day exponential moving average is 46.55 while MRTX share price is 40.72, making it a Sell technically.
  • MRTX stock price is 40.72 and Mirati Therapeutics 200-day simple moving average is 63.60, creating a Sell signal.

Fundamental Analysis of Mirati Therapeutics

Is Mirati Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.32 per share, and an increase next year of $2.26 per share.

Technical Analysis of Mirati Therapeutics

Should I short Mirati Therapeutics stock?

* Mirati Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.